000			02118 a2200661 4500
005			20250517151643.0
264		0	_c20171215
008			201712s 0 0 eng d
022			_a1476-5551
024	7		_a10.1038/leu.2017.120 _2doi
040			_aNLM _beng _cNLM
100	1		_aDispenzieri, A
245	0	0	_aPhase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma. _h[electronic resource]
260			_bLeukemia _c12 2017
300			_a2791-2798 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnimals
650	0	4	_aCell Line, Tumor
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aGenetic Engineering
650	0	4	_aGenetic Therapy _xadverse effects
650	0	4	_aGenetic Vectors _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMeasles virus _xgenetics
650	0	4	_aMice
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xdiagnosis
650	0	4	_aOncolytic Virotherapy _xadverse effects
650	0	4	_aOncolytic Viruses _xgenetics
650	0	4	_aRecurrence
650	0	4	_aSingle Photon Emission Computed Tomography Computed Tomography
650	0	4	_aSymporters _xgenetics
650	0	4	_aTissue Distribution
650	0	4	_aTreatment Outcome
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aTong, C
700	1		_aLaPlant, B
700	1		_aLacy, M Q
700	1		_aLaumann, K
700	1		_aDingli, D
700	1		_aZhou, Y
700	1		_aFederspiel, M J
700	1		_aGertz, M A
700	1		_aHayman, S
700	1		_aBuadi, F
700	1		_aO'Connor, M
700	1		_aLowe, V J
700	1		_aPeng, K-W
700	1		_aRussell, S J
773	0		_tLeukemia _gvol. 31 _gno. 12 _gp. 2791-2798
856	4	0	_uhttps://doi.org/10.1038/leu.2017.120 _zAvailable from publisher's website
999			_c27109780 _d27109780